The approved ALS therapy Radicava may cause serious unexpected side effects, such as liver problems and blood clots, per U.S.

Columnist Dagmar Munn hopes everyone will send out a mayday call during this ALS Awareness Month, to spread the urgent needs ...

Prilenia, Ferrer entered collaboration agreement for commercialization and co-development of pridopidine in Europe and other ...

ALS groups ask lawmakers to preserve federal funding for the National ALS Registry, saying a draft budget memo proposes ...

A protein was created where TDP-43 was fused to the SUMO2 protein and these fusion proteins were expressed in cells with or ...

For ALS Awareness Month this year, advocates want to raise the profile of the neurodegenerative disease in support of care, ...

Treatment with regulatory T-cells, known as Tregs, was well tolerated and seemed to reduce disease activity in a small ...

The 25th anniversary celebration of the Wings Over Wall Street benefit will recognize ALS researchers and advocates.

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

Columnist Juliet Taylor explains how her goals and priorities dramatically shifted while living with her late husband's ALS.

A brain-computer interface that allowed a man, 45, with ALS to communicate using recordings of his own voice has won a $7,500 ...

While life with ALS brings continued disease progression, columnist Kristin Neva is encouraged by signs of renewal outdoors.